Erythromycin in the management of troublesome BCG lesions
- PMID: 6722023
Erythromycin in the management of troublesome BCG lesions
Abstract
We have recently seen six persons with troublesome post-BCG lesions. All lesions healed whilst on therapy with erythromycin for a period of 2-4 weeks. Erythromycin has some effect on the atypical mycobacteria ( Wolinsky et al. 1957) but its use has not previously been described for treatment of BCG lesions.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical